Brain HealthCan Diet, Exercise and Gut Bacteria Tune the Endocannabinoid System in Multiple Sclerosis
The endocannabinoid system (ECS) is a signaling network that helps regulate how nerve cells communicate, how inflamed the nervous system is, and how well the brain adapts. This review asks whether lifestyle factors could tune that network in multiple sclerosis (MS), a chronic immune-driven disease of the brain and spinal cord. The authors find that cannabinoid drugs have a real, established role in easing symptoms, especially the cluster of residual problems called spasticity-plus. Claims about calming microglia, excitotoxicity and inflammation rest mainly on preclinical and mechanistic work. Exercise raises the endocannabinoid anandamide in healthy people, and dietary fats and plant compounds may influence ECS pathways. Gut microbes and the ECS appear to influence each other in experiments. But none of these links has been shown to work through the ECS in people with MS, and none has shown disease-modifying benefit. The authors call this a hypothesis-generating framework and urge prospective validation.